NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

IT Stocks Suffer Significant Losses

Mid- and small-cap information technology (IT) stocks have experienced significant declines over the past six months, with some stocks losing more than a third of their value.

According to a detailed analysis by Mint, the market downturn has raised concerns about the future of alpha returns in the sector. The data suggests that investors are shifting their focus away from traditional growth areas, such as IT, in search of more stable and reliable returns.

Key Statistics:

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

  • Losses of over 30% in value for some mid- and small-cap IT stocks over the past six months
  • Uncertainty surrounding the future of alpha returns in the IT sector

Investor Takeaway

Investors should be cautious of the IT sector's recent performance and potential future returns.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.